Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph S Shapiro

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Hematology|December 2, 2010
Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologistsRalph S Shapiro
Immunotherapy|December 18, 2012
Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapyRalph S Shapiro
Journal of Clinical Immunology|December 25, 2012
Why I use subcutaneous immunoglobulin (SCIG)Ralph S Shapiro
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 22, 2013
Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatricsRalph S Shapiro
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2013
Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysisRalph S Shapiro
Journal of Clinical Immunology|February 26, 2017
Supplement: Frontiers in Immunoglobulin Therapy of Primary Immunodeficiency DiseaseRalph S Shapiro
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|July 2, 2014
Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrateRalph S Shapiro, Lisa Zacek
Journal of Clinical Immunology|August 25, 2012
Payor issues: barriers to optimal management of patients with primary immunodeficiencyRalph S Shapiro, Marcia Boyle
Journal of Clinical Immunology|July 20, 2012
Local and national advocacy supportRalph S Shapiro, Marcia Boyle, Elena E Perez
Journal of Clinical Immunology|December 18, 2012
Clinical ambiguities--ongoing questionsTroy R Torgerson, Vincent R Bonagura, Ralph S Shapiro
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Hematology|December 2, 2010
Malignancies in the setting of primary immunodeficiency: Implications for hematologists/oncologistsRalph S Shapiro
Immunotherapy|December 18, 2012
Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapyRalph S Shapiro
Journal of Clinical Immunology|December 25, 2012
Why I use subcutaneous immunoglobulin (SCIG)Ralph S Shapiro
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 22, 2013
Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatricsRalph S Shapiro
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2013
Subcutaneous immunoglobulin therapy given by subcutaneous rapid push vs infusion pump: a retrospective analysisRalph S Shapiro
Journal of Clinical Immunology|February 26, 2017
Supplement: Frontiers in Immunoglobulin Therapy of Primary Immunodeficiency DiseaseRalph S Shapiro
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|July 2, 2014
Training hereditary angioedema patients to self-administer intravenous C1 esterase inhibitor concentrateRalph S Shapiro, Lisa Zacek
Journal of Clinical Immunology|August 25, 2012
Payor issues: barriers to optimal management of patients with primary immunodeficiencyRalph S Shapiro, Marcia Boyle
Journal of Clinical Immunology|July 20, 2012
Local and national advocacy supportRalph S Shapiro, Marcia Boyle, Elena E Perez
Journal of Clinical Immunology|December 18, 2012
Clinical ambiguities--ongoing questionsTroy R Torgerson, Vincent R Bonagura, Ralph S Shapiro
Pageof 2